New Drugs

Brand/Generic Company Description
Carvykti
ciltacabtagene autoleucel
Janssen

A new B-cell maturation antigen (BCMA)-directed T-cell IV immunotherapy for adults with multiple myeloma.

Kengrexal
cangrelor
Methapharm

A new IV direct P2Y12 platelet receptor inhibitor for patients with coronary artery disease undergoing percutaneous coronary intervention (PCI).

Vegzelma
bevacizumab
Celltrion

A biosimilar to Avastin.

Brand/Generic Company Description
Calquence
acalabrutinib maleate
AstraZeneca

New tablet dosage form that does not interact with gastric acid reducing agents

Brand/Generic Company Description